Results 31 to 40 of about 72,512 (197)
Circulation. Cardiovascular Interventions, 2016 Background—Diabetes mellitus and angiographic coronary artery disease complexity are intertwined and unfavorably affect prognosis after percutaneous coronary interventions, but their relative impact on long-term outcomes after percutaneous coronary ...
K. Koskinas +12 more
semanticscholar +1 more source
Drug-eluting stents : Insights into safety and indications
Annals of Saudi Medicine, 2008 Currently, more than 4 million patients receive drug-eluting stents worldwide. Despite recent studies and editorials that have stirred controversy and generated tremendous publicity in the lay press related to the safety of drug-eluting stents for the ...
Hassan Walid
doaj
Frontiers in Pharmacology, 2020 Drug eluting ureteral stent is an effective means for local drug delivery to the urinary tract. It can potentially solve a variety of upper urinary tract problems, such as stent-related urinary tract infections and discomfort, ureteral stricture, and ...
Hongli Shan +6 more
doaj +1 more source
European Heart Journal, 2016 AIMS Compared with bare metal stents, first-generation drug-eluting stents (DES) are associated with an increased risk of late restenosis and stent thrombosis (ST).
K. Yamaji +14 more
semanticscholar +1 more source
Thrombosis prevention in percutaneous coronary interventions
Кардиоваскулярная терапия и профилактика, 2009 The introduction of drug-eluting stents has been a major achievement of interventional cardiology. These stents demonstrate good clinical effectiveness and safety profile.
V. P. Lupanov, A. N. Samko
doaj
Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost
SAGE Open Medical Case Reports, 2016 Stent fracture is a rare complication of drug-eluting stent implantation with a reported rate of 0.84%–3.2% in various clinical studies with first-generation drug-eluting stents and 29% in autopsy studies.
Alev Arat Ozkan +2 more
doaj +1 more source
Long-term effectiveness and safety of sirolimus drug-eluting stents
Medical Devices: Evidence and Research, 2011 Mahesh Bikkina, Jayanth KoneruSt Joseph Regional Medical Center, Paterson, Seton Hall University, NJ, USAAbstract: The root cause of coronary artery disease is atherosclerosis, ie, intraluminal narrowing (stenosis) of the arteries that supply blood to ...
Bikkina M, Koneru J
doaj
BMC Cardiovascular Disorders, 2022 Background Coronary artery aneurysms after drug eluting stents are rare. We present a case series of type II coronary aneurysms after implantation of Everolimus eluting stents including patients developing giant aneurysms with a toxic course.
Raghav Sharma +2 more
doaj +1 more source
Stent thrombosis in randomized clinical trials of drug-eluting stents.
New England Journal of Medicine, 2007 BACKGROUND Definitions of stent thrombosis that have been used in clinical trials of drug-eluting stents have been restrictive and have not been used in a uniform manner.
L. Mauri +5 more
semanticscholar +1 more source
Second Generation Drug-Eluting Stents: A Review of the Everolimus-Eluting Platform
Clinical Medicine Insights: Cardiology, 2013 Everolimus-eluting stents (EES) represent the next generation of drug-eluting stents (DES). Important design modifications include thin strut stent backbones, less inflammatory and more biocompatible polymers, and lower drug dosing.
Matthew G. Whitbeck, Robert J. Applegate
doaj +1 more source